Naptumomab
Modify Date: 2025-08-25 12:14:33
Naptumomab structure
|
Common Name | Naptumomab | ||
|---|---|---|---|---|
| CAS Number | 1412892-09-1 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of NaptumomabNaptumomab, a tumor targeting superantigen (TTS), is a fusion protein containing. Naptumomab stimulates the immune system to identify and kill tumour cells. Naptumomab can be used for the research of refractory solid tumors such as renal cell carcinoma[1][2]. |
| Name | Naptumomab |
|---|
| Description | Naptumomab, a tumor targeting superantigen (TTS), is a fusion protein containing. Naptumomab stimulates the immune system to identify and kill tumour cells. Naptumomab can be used for the research of refractory solid tumors such as renal cell carcinoma[1][2]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |